Protocol for a phase 2 study of bosutinib for amyotrophic lateral sclerosis using real-world data: induced pluripotent stem cell-based drug repurposing for amyotrophic lateral sclerosis medicine (iDReAM) study

Authors

Institutions

Publication Details

Journal
BMJ Open
Published
2024-10-01
DOI
https://doi.org/10.1136/bmjopen-2023-082142
Citations
8
Primary Topic
Amyotrophic Lateral Sclerosis Research
Type
article
Field-Weighted Citation Impact
2.95

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Protocol for a phase 2 study of bosutinib for amyotrophic lateral sclerosis using real-world data: induced pluripotent stem cell-based drug repurposing for amyotrophic lateral sclerosis medicine (iDReAM) study

Akiko Morinaga, Takehisa Hirayama, Makiko Nagai, Osamu Kano et al.
8 citations
BMJ Open
Amyotrophic Lateral Sclerosis Research
2.95
article

Protocol for a phase 2 study of bosutinib for amyotrophic lateral sclerosis using real-world data: induced pluripotent stem cell-based drug repurposing for amyotrophic lateral sclerosis medicine (iDReAM) study

Akiko Morinaga, Takehisa Hirayama, Makiko Nagai, Osamu Kano, Takao Kiriyama, Takashi Ayaki, Hiroshi Kataoka, Riko Tabuchi, Yuishin Izumi, Ritsuko Hanajima, Hirofumi Maruyama, Gen Sobue, Koji Fujita, Naoto Takahashi, Kazuma Sugie, Motoki Oe, Keiko Imamura, Shotaro Haji, Hitoki Nanaura, Kazutoshi Nishiyama, Masahiro Nakamori, Harutsugu Tatebe, Takenobu Murakami, Naohiro Egawa, Ryōsuke Takahashi, Naoki Atsuta, Yasuhiro Watanabe, Satoshi Morita, Takahiko Tokuda, Haruhisa Inoue, Mihoko Kobayashi, Kasia Lobello
article en
8 citations

Abstract

No abstract available for this paper.
BMJ OpenVol. 14(10)
Hiroshima University (JP), Toho University (JP), Aichi Medical University (JP), Pfizer (United States) (US), Akita University (JP), Kyoto University (JP), National Institutes for Quantum Science and Technology (JP), Pfizer (Japan) (JP), Kyoto University Hospital (JP), Tottori University (JP), Kitasato University (JP), Nara Medical University (JP), Tokushima University (JP)
Pfizer, Japan Agency for Medical Research and Development
Openalex Percentile: Top 8%
Amyotrophic Lateral Sclerosis Research
2.95
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.